Rational Design, Synthesis and Pharmacological Evaluation of Chalcones as Dual-Acting Compounds-Histamine H<sub>3</sub> Receptor Ligands and MAO-B Inhibitors. [PDF]
Łażewska D +15 more
europepmc +1 more source
Management of Central Disorders of Hypersomnolence in Pregnancy and Lactation. [PDF]
Abideen ZU +5 more
europepmc +1 more source
A Comprehensive Review of Current and Emerging Treatments for Narcolepsy Type 1. [PDF]
Xu Q +5 more
europepmc +1 more source
International audienceBackground: Recent studies using opto- or pharmaco-genetics approach targeting histamine (HA) neurons of the tuberomammillary nucleus (TMN) show discrete or mild sleep-wake phenotypes, challenging therefore the role of HA neurons ...
Biolchini, Xavier +5 more
core
Antiseizure Medications that Did Not Reach the Epilepsy Market: An Assessment of Factors Contributing to Their Failed Clinical Development Over the Last Three Decades. [PDF]
Bialer M, Perucca E.
europepmc +1 more source
Development and validation of a method for quantitative determination of the genotoxic impurity diethyl sulfate in pitolisant hydrochloride <i>via</i> high-performance liquid chromatography. [PDF]
Bhagwat S +5 more
europepmc +1 more source
Comparative Efficacy and Safety of Multiple Wake-Promoting Agents for the Treatment of Residual Sleepiness in Obstructive Sleep Apnea Despite Continuous Positive Airway Pressure: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. [PDF]
Tanayapong P +6 more
europepmc +1 more source
Obstructive Sleep Apnoea Treatments-Where Are We Now? [PDF]
Luu S, Lee D, Yee BJ.
europepmc +1 more source
Histamine H3 Receptor as a target for alcohol use disorder: challenging the predictability of animal models for clinical translation in drug development. [PDF]
Le Foll B +19 more
europepmc +1 more source
Trends and variation in issuance of high-cost narcolepsy drugs by NHS England organisations and regions from 2019 to 2022. [PDF]
van Someren F +12 more
europepmc +1 more source

